Inventors:
Serge L. Beaucage - Silver Spring MD, US
Andrzej Wilk - Bethesda MD, US
Andrzej Grajkowski - Bethesda MD, US
Assignee:
The United States of America as represented by the Department of Health and Human Services - Washington DC
International Classification:
C07D407/12
C07H021/00
US Classification:
549472, 536 253, 536 2611
Abstract:
The present invention provides a compound of formula (I), (II), or (III), wherein R, R, R, R, and R are the same or different and each is H an alkyl, an alkenyl, an alkynyl, a cycloalkyl, an aryl, or an aralkyl. Alternatively, either of Ror R combined with either of Ror R comprises a ring. Ris a protecting group or a solid support Ris H or an alkyl. Ris a protecting group, an amidoalkyl, an alkyl, an alkyl ketone, an alkenyl, an alkynyl, a cycloalkyl, an aryl, or an aralkyl. Ris H or a protecting group. Q and Qare the same or different and each is a nucleoside, an oligonucleotide comprising a nucleoside, or an oligomer comprising a nucleoside, which is of formula (a) or (b), wherein B is a labeling group, an alkyl, an alkenyl, an alkynyl, a cyclic group optionally containing one or more heteroatoms, or an amino; and, E is H, a halogen, a hydroxy, an alkoxy, an ester, an amino or a protecting group. X and Xare independently O, S, or Se, and n is an integer from 1 to about 300. Each Q in each monomeric unit defined by n can be the same or different.